Open Access

Table 1

Demographic and surgical details of patients with periprosthetic joint infections (PJIs) following total knee arthroplasty (TKA) treated with a combination of continuous local antibiotic perfusion (CLAP).

Case Age (years) Sex Affected side Comorbidity Body mass index (kg/m2) Smoking status (Brinkman index) Acute/chronic infection Previous TKA surgery (primary/revision) Time from TKA (days) Culture Time from recent infection diagnosis to surgery (days) Surgery CRP negative achievement (days from surgery) Time to 2nd surgery (days) Follow-up period (months) Success /failure
1 86 F R HT 29.4 Nonsmoker Acute Primary 29 Negative 0 DAIR, insert exchange 92 39.6 Success
2 77 M L 24.1 Nonsmoker Acute Primary 204 MSSA 11 DAIR, insert exchange 64 17.5 Success
3 77 F L AP, HT, DLP, DM, asthma, GERD 19.7 Nonsmoker Acute Primary 62 MSSA, Staphylococcus haemolyticus (MRS) 1 DAIR, insert exchange 71 14.2 Success
4 87 M R RA, HT, ARF, prosthesis cancer 25.1 Nonsmoker Acute Primary 623 Escherichia coli 1 DAIR, insert exchange 126 1.49 Success
5 70 F R DM, HT, DLP 27.6 Nonsmoker Acute Revision 21 Staphylococcus epidermidis 3 DAIR, insert exchange 46 11.8 Success
6 49 F L RA 21.3 Nonsmoker Chronic Primary 4113 Staphylococcus epidermidis 416 Implant removal, cement spacers, debridement 14 180 21.2 Success
7 61 F R 38.7 Nonsmoker Chronic Primary 1021 MSSA 17 Implant removal, cement spacers, debridement 32 168 16.5 Success
8 73 F L DM, HT, DLP 24.9 Ex-smoker (200) Chronic Primary 2616 MAC 27 Implant removal, cement spacers, debridement 27 20.3 Success
9 69 F L RA, hypothyroidism 17.7 Nonsmoker Chronic Primary 204 MSSA, Candida 91 Implant removal, cement spacers, debridement 159 112 40.5 Success
10 71 F R 29.1 Nonsmoker Chronic Primary 482 MSSA 72 Implant removal, cement spacers, debridement 168 148 39.9 Success
11 74 M L HT, DLP 28.1 Ex-smoker (1,600) Chronic Revision 1647 Staphylococcus lugdunensis 63 Implant removal, cement spacers, debridement 29 133 20.7 Success
12 58 F R Sjogren disease, DM, RA, asthma, HT, DLP 25.2 Smoker (760) Chronic Revision 316 Staphylococcus epidermidis 193 Implant removal, cement spacers, debridement 102 105 14.2 Success
13 70 M L HT, lung cancer, lymphedema, pulmonary fibrosis 23.5 Smoker (760) Chronic Primary 1844 Staphylococcus lugdunensis 5 DAIR, insert exchange 91 16.2 Failure
71 M L Chronic Primary Staphylococcus lugdunensis 13 Implant removal, cement spacers, debridement 62 20.7 Success
14 51 M L 22.5 Smoker (1,120) Chronic Primary 247 Staphylococcus hominis 5 DAIR, insert exchange 71 19.4 Failure
52 M L Chronic Primary Bacillus species 28 Implant removal, cement spacers, debridement 56 14.0 Success

HT, hypertension; AP, angina pectoris; DLP, dyslipidemia; DM, diabetes mellitus; GERD, gastroesophageal reflux disease; ARF, acute renal failure; RA, rheumatoid arthritis; MSSA, methicillin-sensitive Staphylococcus aureus; MRS, methicillin-resistant Staphylococcus; MAC, Mycobacterium avium complex; DAIR, debridement, antibiotics and implant retention; CRP, C-reactive protein.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.